// App-Quantinova.ai

M5009 2016 AHA : Vascular Endothelial Growth Factor Myocardial Cell Anti-apoptotic Events Requires S100A6 Signaling

Researchers

Presenter

  • Ioannis K Rizos

Principal Investigators

  • Vasileios Salpeas

  • Shehla Izhar

  • Gerald Proteau

  • Thomas G Parker

Medical Centers

  • St. Michael's Hosp, Toronto, ON, Canada

  • Attikon University Hospital, Athens, Greece.

Locations

  • Canada

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • B-cell lymphoma 2

  • BCL2 associated X, apoptosis regulator

  • Carboxypeptidase B1

  • Proto-oncogene tyrosine-protein kinase ROS

  • Fms related tyrosine kinase 1

  • Kinase Insert Domain Receptor

  • S100 Calcium Binding Protein A6

  • S100 calcium-binding protein B

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim